It has been suggested that increased levels of ACE2 positively correlate with COVID-19, thus the stabilization of HIF1α which in turn, down regulates the ACE2 gene, could improve the outcomes in COVID-19 patients [37,38]. This evidence concerns the gene ACE2 and COVID-19.